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Atrial fibrillation (AF) is the most common form of
sustained clinical arrhythmia. We previously mapped
an AF locus to chromosome 5p13 in an AF family with
sudden death in early childhood. Here we show that
the specific AF gene underlying this linkage is
NUP155, which encodes amember of the nucleopor-
ins, the components of the nuclear pore complex
(NPC). We have identified a homozygous mutation,
R391H, in NUP155 that cosegregates with AF, affects
nuclear localization of NUP155, and reduces nuclear
envelope permeability. Homozygous NUP155/
knockout mice die before E8.5, but heterozygous
NUP155+/ mice show the AF phenotype. The
R391H mutation and reduction of NUP155 are asso-
ciated with inhibition of both export of Hsp70 mRNA
and nuclear import of Hsp70 protein. These human
and mouse studies indicate that loss of NUP155
function causes AF by altering mRNA and protein
transport and link the NPC to cardiovascular disease.
INTRODUCTION
Internal compartmentalization of eukaryotic cells was a critical
stage of evolution which enclosed genetic information inside
the nucleus and spatially separated it from the rest of the cell
(Hoelz and Blobel, 2004). Transport of macromolecules between
the nucleus and cytoplasm is a critical cellular process for
eukaryotes which directly affects gene expression and signal
transduction (Taddei et al., 2006; Terry et al., 2007). The nuclear
pore complex (NPC) is an evolutionarily conserved structure that
spans the nuclear envelope (NE) and mediates bidirectional
exchange of macromolecules (mRNAs and proteins) betweenthe nucleus and cytoplasm (Weis, 2003). The NPC was first
recognized in the 1960s, but its role as a mediator of nucleocyto-
plasmic transportwasnotdefinitivelydemonstrateduntil 20 years
later (Stewart et al., 2007). The NPC allows for the passive diffu-
sion of molecules of relative molecular mass of 40,000, but ac-
tively transports large macromolecules, such as proteins,
RNAs, and ribonucleoprotein particles, through shuttling trans-
port receptors (Gorlich and Kutay, 1999). The NPC is composed
of some30different nucleoporins that areeachpresent inmultiple
copies. Extensive electron microscopy and tomography studies
in addition to an innovative strategy involving biophysics, proteo-
mics, and sophisticated computation has revealed the general
morphology of the NPC (Alber et al., 2007a, 2007b; Beck et al.,
2004; Hinshaw et al., 1992). The overall shape and architecture
of the NPC is conserved from yeast to higher eukaryotes.
Nucleoporins are the critical molecular components for the
assembly and function of the NPC. NUP155 is a nucleoporin
with a calculatedmolecularmass of about 155 kDa and is amajor
component of the NPC (Zhang et al., 1999). The first NUP155
gene was cloned from the rat by Radu et al. in 1993, and was
shown to be associated with both nucleoplasmic and cytoplas-
mic aspects of the NPC (Radu et al., 1993). Nevertheless, the
in vivo physiological roles of NUP155 in mammalian systems
are unknown. In this study, we employed both human genetic
and mouse gene-targeting approaches to demonstrate the es-
sential roles of NUP155 in cardiac physiology and further link it
to the most common clinical cardiac arrhythmia, atrial fibrillation
(AF), and early sudden death.
AF is a cardiac disorder characterized by supraventricular
tachyarrhythmia due to uncoordinated atrial activation, a rapid
atrial rate of 150–300 beats/min, absence of P waves, presence
of rapid oscillations or fibrillatory waves (f waves), and inconsis-
tent R-R intervals on electrocardiograms (ECG) (Fuster et al.,
2001). The prevalence of AF is increasing rapidly as the popula-
tion ages, and reaches more than 8% for people aged 80–89
years (Peters et al., 2002). More than 15% of strokes are causedCell 135, 1017–1027, December 12, 2008 ª2008 Elsevier Inc. 1017
by AF (Fuster et al., 2001; Peters et al., 2002). AF is also associ-
ated with worsening heart failure and increased mortality (Save-
lieva and John, 2004). Common AF is a complex disease, and its
pathogenesis involves multiple genetic factors, environmental
factors, and interactions among these factors. Nearly 30% of AF
patients present with either an autosomal dominant or recessive
familial history (Oberti et al., 2004;Wang, 2008). Although raremu-
Figure 1. Genotyping and Linkage Analysis
of an AF Family, arAF1
(A) Genotyping results are shown for an affected
member (boxed VI:3), a newly born male in the
arAF1 family, together with the results for other
family members reported previously (Oberti et al.,
2004). The new affected male patient, VI:3, was
genotyped with five linked markers at the arAF1
locus, including D5S493, D5S426, D5S455,
D5S1998, and D5S1964. Affected individuals are
shown as filled squares (males) and circles (fe-
males); normal individuals are indicated by empty
symbols; obligate heterozygous carriers are
shown with dots in symbols; deceased family
members are shown with slashes (/); the proband
is indicated by an arrow.
(B) Multipoint LOD score analysis. Genotypes at
D5S1506, D5S426, D5S493, D5S455, D5S1998,
D5S1964, and D5S1490 were used to determine
multipoint LOD scores at chromosome 5p13.
D5S1506 was arbitrarily plotted at 0 cM at the
abscissa. Other microsatellite markers near the
arAF1 locus are indicated along the abscissa
from telomere to centromere. Multipoint LOD
scores were plotted on the ordinate.
tations in ion channels have been identi-
fied in a few families with AF, the genetic
basis for the majority of AF cases remains
largely unknown (Wang, 2008). We have
previously reported a large AF family with
an autosomal recessive inheritance pat-
tern and identified the first genetic locus
for autosomal recessive AF to chromo-
some 5p13 (arAF1) (Oberti et al., 2004).
In this study, we provide evidence dem-
onstrating that the AF gene at the 5p13
arAF1 locus is the NUP155 gene. The
results provide a novel non-ion-channel
mechanism for the pathogenesis of AF
and, to our knowledge, link the NPC to
cardiovascular disease for the first time.
RESULTS
Genetic Linkage of Autosomal
Recessive AF
to Chromosome 5p13 in the
Expanded arAF1 Family
and Fine Mapping
We previously mapped an autosomal re-
cessive AF locus to chromosome 5p13
in a large arAF1 family (Oberti et al., 2004). After the initial publi-
cation, a new affected male was born (individual VI:3; Figure 1A).
This patient was genotyped with five markers linked to AF at
the arAF1 locus, D5S493, D5S426, D5S455, D5S1998, and
D5S1964, and was linked to all five. The maximum two-point
logarithm of the odds (LOD) score, at a recombination fraction
of 0, increased from the previous 3.05 to 4.04 in the expanded1018 Cell 135, 1017–1027, December 12, 2008 ª2008 Elsevier Inc.
pedigree (see Table S1 available online). The maximum multi-
point LOD score increased from 4.10 to 4.40 (Figure 1B). These
results strengthen a linkage of AF to chromosome 5p13.
Fine mapping, with single-nucleotide polymorphisms (SNPs)
in the region, restricted the 5p13 AF locus between the NPR3
gene (physical location, 32,747,422) andPTGER4 (physical loca-
tion, 40,729,594). A systematic mutational analysis was initiated
to identify the AF gene by direct DNA sequence analysis. On
the right side of the AF locus, sequence analysis of OSMR,
FYB, and FLJ39155 (now known as EGFLAM; physical location,
38,501,338) identified an SNP in EGFLAM that showed a recom-
bination event with AF in the family, further defining the AF locus
within a 5.75 Mb interval.
A Missense Mutation in NUP155 Cosegregates
with AF in the arAF1 Family
We systematically analyzed almost all the known and putative
genes within the refined arAF1 locus (not including the known
disease-causing genes, SMN1 and SMN2, for amyotrophic
lateral sclerosis and spinal muscular atrophy, GDNF for Hirsch
Sprung disease, and NIPBL for Cornelia de Lane syndrome).
All exons and exon-intron boundaries of the regional candidate
genes were sequenced in two DNA samples, one from the
affected individual V-11 (Figure 1A) and the other from a normal
control individual. The only mutation identified was a homozy-
gous mutation, R391H, in the nucleoporin 155 gene (NUP155)
(Figure 2A). The R391H mutation occurs in exon 11 at an
evolutionarily, highly conserved arginine (R) residue (Figure 2B).
In addition, 1700 control individuals did not carry the mutation
(data not shown). All affected members of the arAF1 family
carried the homozygous R391H mutation, whereas all obligate
carriers carried the heterozygous mutation. All normal family
members were mutation negative (Figure 3). These results pro-
vide strong direct genetic evidence that the R391H is a patho-
genic mutation that causes AF in the family.
Mutation R391H Affects Nuclear Envelope Localization
of NUP155 Protein and Nuclear Envelope Permeability
We hypothesized that incorrect NE localization of NUP155,
mediated by the R391H mutation, is a mechanism for the path-
ogenesis of AF. To test the hypothesis, we evaluated the nuclear
localization of wild-type (WT) and R391H mutant NUP155 pro-
teins in COS7 cells. COS7 cells were transiently transfected
with mammalian expression constructs for enhanced green
fluorescent protein (EGFP) -tagged WT or R391H mutant
NUP155 proteins. Wild-type NUP155 protein localized, in a
strong, tight, and punctuated manner with many NE foci (Fig-
ure 4A). In contrast, R391H mutant NUP155 protein failed to vis-
ibly accumulate at various NE foci and was diffusely distributed
toward and in the cytoplasm. Identical results were obtained by
immunostaining studies of COS7 cells transfected with either
Flag-tagged WT or R391H mutant NUP155 constructs (Fig-
ure 4B). These results suggest that the R391H mutation in
NUP155 affects the targeting of NUP155 protein to specific sites
(presumably the NPC) on the NE. The functional effect of the
R391H mutation was tested by a newly developed assay for
NE permeability (Grote and Ferrando-May, 2006). Compared
to HeLa cells without transfection or cells with transient expres-sion of WT NUP155, cells with R391H mutant NUP155 showed
significantly reduced NE permeability (Figures 4C and 4D). The
R391H mutation may act by a loss-of-function mechanism con-
sistent with the common mechanism of most recessive human
diseases.
Heterozygous NUP155+/ Knockout Mice
Are Associated with AF
To further strengthen the link between NUP155 and AF, we
developed a knockout mouse line targeting NUP155 by the
Figure 2. Identification of a Novel R391H Mutation in NUP155
Associated with AF
(A) DNA sequences of exon 11 ofNUP155 from a normal individual, an obligate
carrier, and an affected family member.
(B) The R391H mutation is located in exon 11 and occurs at an arginine (R)
residue that is highly evolutionarily conserved.Cell 135, 1017–1027, December 12, 2008 ª2008 Elsevier Inc. 1019
Figure 3. Cosegregation of NUP155 Mutation R391H with AF in the Family
R, wild-type R391 allele; H, mutant H391 allele.gene-trapping strategy. The trapping vector was inserted in
intron 5 of the mouse NUP155 gene, which results in a trun-
cated mNUP155 protein of only 217 amino acids (the normal
NUP155 contains 1391 amino acids) (Figure 5A). Homozygous
NUP155/ mice died during embryogenesis before embry-
onic day 8.5, whereas heterozygous NUP155+/ mice were vi-
able. Semiquantitative RT-PCR and western blot analyses
showed that the expression levels of mouse NUP155 mRNA
and protein were significantly reduced by about 50% in het-
erozygous NUP155+/ knockout mice compared with wild-
type littermate control mice (Figures 5B and 5C). This result
was confirmed using immunostaining with an anti-NUP155
antibody (Figure 5D). The immunostaining study also demon-
strated that NUP155 was strongly expressed in atrial myo-
cytes (Figure 5D). Continuous telemetry ECG recordings from
conscious, freely moving mice revealed significant similarities
in cardiac phenotype between human AF patients and
NUP155+/ mice (Figure 6). The observed AF phenotype can
sustain for 10 min or longer. The main AF-related phenotypes
include (1) absence of discrete P waves, and (2) irregular R-R
intervals (Figure 6). These results indicate that downregulation
of NUP155 expression by haploinsufficiency (50%) causes AF
in mice.1020 Cell 135, 1017–1027, December 12, 2008 ª2008 Elsevier Inc.Mutant NUP155 Reduces Atrial Action Potential
Duration and Inhibits Export of Hsp70 mRNA and
Nuclear Import of Hsp70 Protein
Histological analysis of NUP155+/ knockout mice did not reveal
any overt structural abnormalities in heart and skeletal muscle
(data not shown), the two organs demonstrating the highest ex-
pression levels of NUP155 (Zhang et al., 1999). Immunostaining
with cardiac-specific a-actinin of NUP155+/ hearts did not re-
veal obvious differences in the morphology of cardiomyocytes
and the atrial tissue architecture (Figure 7A). We then examined
NUP155+/ atrial myocytes for electrophysiological alternations.
Compared to NUP155+/+ cells, atrial myocytes from NUP155+/
mice showed significantly shortened action potential duration
(Figure 7B), which is involved in induction and maintenance of
AF (Nattel, 1999; Van Wagoner and Nerbonne, 2000).
To identify a molecular mechanism by which mutant NUP155
causes AF, we tested the hypothesis that NUP155 mutation
R391H or the reduction of NUP155 may affect mRNA export of
Hsp70. Export ofHsp70mRNA is inhibited by siRNA knockdown
of expression of hCG1, which forms a complex with NUP155 and
hGle1 (Kendirgi et al., 2005). RT-PCR showed that HeLa cells
with transient expression of wild-type NUP155 increased export
of Hsp70 mRNA, but cells with mutant NUP155 exhibited
significant reduction of mRNA export (Figure 7C). Similarly, car-
diomyocytes from NUP155+/ mice showed significantly re-
duced export of Hsp70 mRNA compared to those from
NUP155+/+ mice (Figure 7D). These results demonstrate that
NUP155 dysfunction significantly inhibits export of Hsp70
mRNA to the cytoplasm. Immunostaining with an anti-Hsp70 an-
tibody showed that overall expression levels of Hsp70 protein
were reduced in HeLa cells with transient expression of mutant
NUP155 protein (Figure 7C) or in NUP155+/ myocytes (Fig-
ure 7D), consistent with the results of reduced export of Hsp70
mRNA from RT-PCR analysis. Interestingly, nuclear import of
Hsp70 protein was also inhibited in HeLa cells with transient ex-
pression of mutant NUP155 protein (Figure 7C) or in NUP155+/
myocytes (Figure 7D). Similar studies were carried out for Hsp27,
Figure 4. Mutation R391HAffects the Local-
ization of NUP155 on the Nuclear Envelope
and Reduces the Permeability of the
Nuclear Envelope
(A) EGFP-NUP155.
(B) Flag-NUP155. Wild-type NUP155 (WT) is con-
centrated in foci at the nuclear envelope, whereas
R391H mutant NUP155 failed to visibly accumu-
late in foci at the nuclear envelope and was
diffusely distributed throughout the cytoplasm.
(C) Nuclear envelope permeability assays by influx
of Texas red-labeled dextran (70 kDa) into nuclei of
semipermeabilized HeLa cells. Top panel, fluores-
cence images; bottom panel, images of bright field
from the same slides.
(D) Quantification of fluorescence intensity from
images from permeability assays. A total of 120
fluorescence images (403) was analyzed for
each sample. Mean ± SEM: 57.09 ± 5.21 for con-
trol cells without transfection, 54.18 ± 5.46 for cells
with transient expression of WT NUP155, and
41.30 ± 2.06 for cells with transient expression of
mutant NUP155. The results were analyzed by
one-way ANOVA analysis.
but no significant abnormalities in either
mRNA export or protein nuclear import
were detected (data not shown).
DISCUSSION
Our studies in both humans and mice
provide strong evidence for the role of
a nucleoporin, NUP155, in the physiology
of the heart and the pathogenesis of
AF, the most common clinical cardiac
arrhythmia. Multiple lines of evidence in-
dicate that NUP155 is the AF gene on
chromosome 5p13. First, we identified
significant genetic linkage between
markers flanking NUP155 and AF in a
large family with single and multipoint
LOD scores of 4.04 and 4.40, respec-
tively. Second, we identified a novel ho-
mozygous mutation, R391H in NUP155,
that cosegregates with AF in the AF family, but does not exist
in 1700 controls. Third, we demonstrated that the R391H muta-
tion affects the NE localization of NUP155 and reduces NE
permeability. Fourth, we demonstrated strong expression of
NUP155 protein in atrial myocytes. Finally, heterozygous
NUP155+/ knockout mice showed the AF phenotype, which
supports the conclusion that NUP155 is a disease-causing
gene for AF.
Additional evidence supports a role of NUP155 in the patho-
genesis of AF. The human NUP155 gene was reported to display
a tissue-specific expression pattern (Zhang et al., 1999). North-
ern blot analysis identified a 5.4 kb transcript that showed the
highest expression level in two organs, the heart and skeletal
muscle (Zhang et al., 1999). Immunostaining studies alsoCell 135, 1017–1027, December 12, 2008 ª2008 Elsevier Inc. 1021
demonstrated strong expression of NUP155 in isolated atrial my-
ocytes (Figure 5). These results are consistent with our conclu-
sion that defects in NUP155 are associated with AF and provide
an explanation as to why the heart is the major organ affected by
the loss of function of an essential nucleoporin gene, such as
NUP155.
To date, our understanding of the genetic basis of AF ismostly
limited to genes encoding ion channels. Rare mutations associ-
ated with AF have been reported in genes encoding potassium
channels, and somatic mutations in the GJA5 gene encoding
connexin40 were identified in tissues from three sporadic AF pa-
tients (Wang, 2008). However, the genetic basis for the majority
of AF cases remains largely unknown. Positional cloning, based
on genome-wide linkage analysis, in large families is the most
effective and convincing approach for identifying disease-caus-
Figure 5. Characterization of Heterozygous
NUP155+/ Knockout Mice
(A) Strategy for developing a gene-trapping mouse
line targeting NUP155. The b-geo insertion vector
is in intron 5. PCR with primer P1 (50-ATG GAT
GGA GTT AGA TCC CTT AGA C-30) and P2 (50-
AAG ATT CTG CCA TTA TCC GTG GAC-30) iden-
tifies the wild-type NUP155 allele, whereas the
mutant, trapped NUP155 allele is detected by
PCR with primers P1 and P3 (50-GTT TCC TTG
AAG GAC TCC AAT-30). SA, splicing acceptor.
(B) Semiquantitative RT-PCR analysis showed
reduced expression of NUP155 by 2-fold in
heterozygous NUP155+/ mice compared to
wild-type NUP155+/+ mice.
(C) Western blot analysis with an anti-NUP155
antibody demonstrated 50% reduction of
NUP155 expression in heterozygous NUP155+/
mice compared to wild-type NUP155+/+ mice.
(D) Immunostaining with an anti-NUP155 antibody
showed expression of NUP155 in isolated atrial
myocytes. Expression of the NUP155 protein
was reduced by 50% in heterozygous NUP155+/
mice compared to wild-type NUP155+/+ mice.
The data are shown as mean ± SEM.
ing genes. The initial AF-causing muta-
tion in KCNQ1 was identified by a posi-
tional candidate gene approach,
whereas other ion-channel genes asso-
ciated with AF were identified by the
candidate gene approach in sporadic
patients or small nuclear families
(Wang, 2008). NUP155 is another AF
gene identified by a positional cloning
approach. Most importantly, results
from this study provide a novel non-
ion-channel mechanism underlying the
pathogenesis of AF. After the submis-
sion of this manuscript, a heterozygous
mutation in the NPPA gene encoding
atrial natriuretic peptide was identified
in a family with autosomal dominant AF
(Hodgson-Zingman et al., 2008), which provides further support
for a non-ion-channel basis of AF.
Our data predict a likely cellular mechanism for the patho-
genesis of AF. NUP155 has been demonstrated to interact
with an mRNA export factor, Gle1 (Kendirgi et al., 2005; Rayala
et al., 2004). The N-terminal 29 amino acid residues of hGle1
are responsible for the interaction with NUP155 and for the tar-
geting of hGle1 to the NPC (Rayala et al., 2004). Further studies
showed that NUP155, hGle1, and nucleoporin hCG1 form a het-
erotrimeric complex, and siRNA knockdown of hCG1 expres-
sion is associated with inhibition of export of Hsp70 mRNA
and nuclear accumulation of Hsp70 mRNA (Kendirgi et al.,
2005). Based on these results, we predict that NUP155 defi-
ciency may cause molecular remodeling of gene expression
by affecting mRNA export of key atrial genes from the nucleus1022 Cell 135, 1017–1027, December 12, 2008 ª2008 Elsevier Inc.
Figure 6. Detection of the Phenotype of AF in Heterozygous NUP155+/ Knockout Mice
Telemetric ECG recordings detected the development of atrial fibrillation in NUP155+/ mice, but not in NUP155+/+ mice. Traces are shown as time frame
durations in seconds with ECG signals in mV. One representative trace from NUP155+/+ mice and three traces from three different NUP155+/ mice are
shown.to the cytoplasm. Thus, NUP155 may act as a key upstream
gene that causes AF by regulating the expression of down-
stream genes by controlling mRNA nucleocytoplasmic export.
The specific downstream target genes of NUP155, in the atria,
remain to be identified. However, Hsp70 may be an interesting
candidate gene. Indeed, the R391H NUP155 mutation and the
reduction of NUP155 in heterozygous mice inhibit export of
Hsp70 mRNA and nuclear import of Hsp70 protein (Figure 7).
Multiple reports link Hsp70 to AF. Patients with high Hsp70
expression levels have a lower incidence of postoperative AF
(Kampinga et al., 2007; Mandal et al., 2005; St. Rammos
et al., 2002). An M439T substitution in Hsp70 was associated
with an increased risk of postoperative AF (Afzal et al., 2008).
Cardiomyocytes from Hsp70 knockout mice exhibit delayed
calcium transient decline and reduced sarcoplasmic reticulum
calcium content (Kim et al., 2006). An abnormality in intracellu-
lar Ca2+ homeostasis may be associated with AF (Chou et al.,
2008). Heat shock proteins such as Hsp70 play important roles
in protein folding, trafficking, and cell signaling. We propose
that NUP155 may indirectly modulate maturation and traffick-
ing of calcium handling proteins and ion channels through
regulation of mRNA and protein transport of Hsp70 or other im-
portant atrial proteins, which may provide an explanation for
our finding that the action potential duration from NUP155+/
atrial myocytes is shorter than that from control NUP155+/+
cells (Figure 7B).The function of NUP155 has been explored with a variety of
biochemical and cell biological approaches. The human and
mouse NUP155 genes were cloned by Zhang et al. in 1999
and 2002, respectively (Zhang et al., 1999, 2002). NUP155 is
evolutionarily conserved from yeast, Arabidopsis, Caenorhabdi-
tis elegans, Drosophila, mice, and rats to humans. Immunode-
pletion and siRNA studies, in C. elegans embryos and Xenopus
laevis egg extracts, indicated that NUP155 has an essential
function in the formation of the NE (Franz et al., 2005). The
results in this study indicate that NUP155 is involved in both ex-
port of Hsp70mRNA and nuclear import of Hsp70 protein. How-
ever, the in vivo physiological roles of NUP155 in mammalian
systems are unknown. Here we generated a knockout mouse
line targeted to NUP155. Homozygous NUP155/ mice died
before E8.5, suggesting that NUP155 is essential for embryo-
genesis. Heterozygous NUP155+/ mice showed an interesting
phenotype of AF, the most common clinical cardiac arrhythmia.
The mouse data were further extrapolated with genetic studies
of human patients showing association of NUP155 with AF.
These results reveal a novel role for NUP155 in cardiac physiol-
ogy and link the NPC to cardiovascular disease. NUP155 defi-
ciency may affect the formation of the NE, and delay or block
mitosis, which may reduce myocyte survival. In the long run,
myocyte apoptosis and cardiac fibrosis may occur, creating
substrate for the initiation and maintenance of AF (Ehrlich
et al., 2008).Cell 135, 1017–1027, December 12, 2008 ª2008 Elsevier Inc. 1023
Figure 7. NUP155 Defects Reduce Atrial Action Potential Duration, Export of Hsp70 mRNA, and Nuclear Import of Hsp70 Protein
(A) Immunostaining of atria and ventricles from NUP155+/+ and NUP155+/ mice for a-actinin.
(B) Representative action potential recordings fromNUP155+/+ andNUP155+/ atrial cells. Action potential durationwasmeasured at 90% repolarization (APD90).
The mean averages from each cell (n = 12 cells; 3 mice total for each group) were then pooled together for a group average and summarized.
(C) Analyses of export of Hsp70mRNA and import of Hsp70 protein in HeLa cells transiently transfected using wild-type (WT) or mutant (MT) NUP155 expression
plasmids. Cells without transfection were used as a control. Forty-eight hours after transfection, cells were heat shocked for 2.5 hr, and total RNA from nuclear
and cytoplasmic fractions was isolated and reverse transcribed with an oligo(dT)15 primer. Quantitative real time RT-PCR analysis was then used to estimate the
levels of Hsp70mRNA in the cytoplasm and nucleus (left panel). All the samples were analyzed in triplicate and the results were replicated in three independent
experiments. The heat-shocked cells were stained with an anti-Hsp70 antibody (red) and DAPI for nuclei (blue) (middle panel). Fluorescence intensity in the whole
cell or in the nucleus alone was quantified and is shown as a graph (right panel). n, number of images analyzed.1024 Cell 135, 1017–1027, December 12, 2008 ª2008 Elsevier Inc.
Clinical findings associated with the NUP155 mutation is of
particular interest, as NUP155mutation carriers were associated
with a presentation of in utero and neonatal AF as well as early
sudden death (Oberti et al., 2004). The proband (V:11) and AF pa-
tients V:9, V:10, and VI:1 (Figure 1A) all died suddenly at the age
of 15, 3, 3, and 18 months, respectively. The sole survivor, at the
time of the prior publication (Oberti et al., 2004), AF patient VI:2
(Figure 1A), died recently at the age of 20 months. The early
deaths in the family may be related to AF-induced ventricular
tachyarrhythmias and nonischemic cardiomyopathies (Knight,
2003; Shinbane et al., 1997).
In humans, only homozygous carriers with mutation R391H
were affected with AF, whereas heterozygous carriers were
asymptomatic. On the other hand, heterozygous NUP155+/
mice developed AF. This may be due to a possibility that the
R391H mutant NUP155 allele is a weaker mutation than haploin-
sufficiency. The R391Hmutant NUP155 protein may retain some
residual nucleoporin activity, and causes AF in the human, only
when it is in the homozygous state. Future studies are needed
to clarify this issue.
Laramie et al. identified a putative locus that influences
resting heart rate, with suggestive evidence of linkage to
markers on chromosome 5p13 (LOD score of 1.96) (Laramie
et al., 2006) which overlaps with our 5p13 AF locus. It is also
interesting to note that heterozygous NUP155+/ mice show
a variable heart rate (Figure 6). It is possible that NUP155 vari-
ants will also be associated with variation of the human resting
heart rate.
In conclusion, our findings identify a novel molecular, non-ion-
channel determinant for AF, and extend the understanding of the
nuclear pore complex to cardiovascular physiology. To our
best knowledge, this study is the first to link a nucleoporin defect
to cardiovascular disease. The molecular identification of
NUP155 as an AF gene may facilitate the development of new
diagnostic and therapeutic tools for prevention and treatment
of AF.
EXPERIMENTAL PROCEDURES
Study Subjects and Linkage Analysis
Study subjects involved were enrolled as described previously (Oberti et al.,
2004). The new patient VI:3 (Figure 1A) was born on February 14, 2007 with
AF and atrial tachycardia. The patient is currently in sinus rhythm and on prop-
ahenol, propranolo, and aspirin. This study was approved by the Cleveland
Clinic Institutional Review Boards on Human Subject Research and informed
written consent was obtained for each study subject. Whole blood (10–20
ml) was obtained from each subject and human genomic DNA was isolated
from the whole blood using the DNA isolation kit for mammalian blood (Roche
Diagnostic).
Genotyping of polymorphic microsatellite markers was carried out as de-
scribed previously (Wang et al., 1995, 1996). Phenotyping data, genotyping
data, and pedigree information were used for pairwise linkage analysis using
the Fastlink software package (Cottingham et al., 1993). Single-point and mul-
tipoint linkage analyses were performed assuming an autosomal recessive
pattern of inheritance, a disease-allele frequency of 0.001, and penetrance
of 0 for carriers and noncarriers and 0.99 for homozygous affected individuals.Logarithm of the odds (LOD) scores were calculated as described previously
(Oberti et al., 2004).
Mutational Analysis
Mutation screening was carried out using direct DNA sequence analysis. All
exons and exon-intron boundaries of each candidate gene were PCR ampli-
fied. The PCR products were purified using the PCR purification kit (QIAGEN)
and subjected to DNA sequencing analysis using both forward and reverse
primers using the ABI BigDye Terminator Cycle Sequencing kit v1.1 with an
ABI PRISM 3100 Genetic Analyzer (Applied Biosystems).
Cell Culture and Immunostaining
COS7 cells were maintained in Dulbecco’s minimum essential media (DMEM)
supplemented with 10% heat-inactivated fetal bovine serum (Invitrogen).
Transfection of COS7 cells (106 cells) was carried out with 2 mg of each mam-
malian expression construct for NUP155, including p3xFlag-WT-NUP155 and
p3xFlag mutant-NUP155 using Lipofectamine 2000 (Invitrogen). Cells were
plated on coverslips in a 10 cm plate for 12 hr before the transfection. Forty-
eight hours after the transfection, immunostaining was carried out with the
M2 anti-FLAG monoclonal antibody (Sigma) as the primary antibody and
a FITC-conjugated anti-mouse antibody (Sigma) as the secondary antibody.
Cells in coverslips were fixed in 4% paraformaldehyde/PBS for 15 min at
room temperature, treated with 0.5% Triton X-100, and then blocked in 5%
milk in PBS + Tween 20 (PBST) for 1 hr. The coverslips were then incubated
with the M2 anti-FLAG monoclonal antibody (1:1000 dilution in 5% milk in
PBST) for 12 hr at 4C, washed with PBST, and incubated with the secondary
FITC-conjugated anti-mouse antibody (1:1000 dilution in 5%milk in PBST) for
1 hr at room temperature. Then, 1–2 drops of Vectashield containing 40,6-dia-
midino-2-phenylindole (DAPI) was added and the coverslips were placed on
the slides, sealed with nail oil, air-dried, and analyzed under an IX81 motorized
inverted research fluorescence microscope (Olympus).
COS7 cells were also transfected with expression constructs for EGFP-
tagged NUP155, pEGFP-WT-NUP155, or pEGFP mutant-NUP155 as de-
scribed above. The cells on the coverslips were examined directly under an
IX81 motorized inverted research fluorescence microscope (Olympus).
Quantitative RT-PCR Analysis
Total RNAwas prepared from heart tissue of the heterozygousNUP155 knock-
out and wild-type mice. Total RNA was then isolated using the TRIzol reagent
(Invitrogen). Double-stranded complementary DNA (ds-cDNA) was synthe-
sized from 16 mg of total RNA using Stratagene’s RT-PCR kit. For semiquanti-
tative RT-PCR, we designed the primers to amplify exons 23 and 24 of the
mouse NUP155 gene. The forward primer is 50-GAA TTT CAA GAG CAG
CTG AAG ATC A-30 and the reverse primer is 50-CTT GCC TAT ACT GAG
CAC AGA CAC-30. 18S rRNA primers were used as an internal control (Tian
et al., 2004a). The number of cycles for PCR was optimized for each sample
to obtain data in the linear range for quantification. The PCR profile was 25
cycles (for NUP155) or 18 cycles (for the 18S RNA) of denaturation (94C for
30 s), annealing (55C for 30 s), and extension (72C for 1 min) and a final
extension step of 10 min at 72C. The PCR products were separated on a
1% agarose gel.
Western Blot Analysis
Western blot analysis was carried out with an anti-NUP155 antibody raised
against C-terminal residues (VQAITGNFKSLQAKLERLH; a kind gift from S.R.
Wente; Kendirgi et al., 2005).
Generation of NUP155 Knockout Mice
To demonstrate that NUP155 is a causative gene for AF, we developed
a knockout mouse line targeting NUP155. A gene-trapping embryonic stem
(ES) cell line for NUP155, RRD107, was identified from the BayGenomics(D) Analyses of export of Hsp70mRNA and import of Hsp70 protein in neonatal myocytes isolated from wild-type NUP155+/+ (WT) and heterozygous NUP155+/
(HTZ) mice. Neonatal myocytes were heat shocked for 2.5 and 3.5 hr for RT-PCR analysis or 2.5 hr for immunostaining and analyzed as described in (C). Green
signal, Hsp70 protein; blue signal, DAPI staining for nuclei; n, number of mice used for the assay.
The data are shown as mean ± SEM.Cell 135, 1017–1027, December 12, 2008 ª2008 Elsevier Inc. 1025
database (http://baygenomics.ucsf.edu/). The ES cell line was recovered and
resequenced to confirm its identity. The Bay Genomics/University of
California, Davis facility performed blastocyst injection of the ES cells, which
yielded 13 chimeras (11 males and 2 females) and successful germline trans-
mission.
Isolation of Mouse Atrial Myocytes, Measurements of Action
Potential Duration, and Immunocytochemistry
The procedures for isolation of atrial myocytes from mice were modified from
Rose et al. (2004), and detailed protocols are included in Supplemental Data.
The action potential duration of isolated atrial myocytes was measured as
described previously (Tian et al., 2004b; Yong et al., 2007).
Isolated atrial myocytes were seeded onto carbon-coated glass coverslips
and washed with PBS (pH 7.4) (Sigma). The myocytes were fixed in 10% neu-
tral buffered formalin (Sigma) for 15 min, washed three times with PBS, and
permeabilized by incubation in PBS containing 0.1 Triton X-100 for 10 min. Af-
ter washing three times with PBS, the myocytes were blocked in 10% normal
goat serum (NGS; Sigma) in PBS for 60 min, and incubated with a 1:100 con-
centration of the anti-NUP155 antibody diluted with PBS containing 1% BSA
and 10% NDS in a humid box at 4C overnight. After washing three times
with PBS, the myocytes were incubated with goat anti-rabbit IgG conjugated
to FITC (Sigma) in a humid box at room temperature in the dark for 1 hr. After
washing three times with PBS, the myocytes were mounted with Vectashield
mounting media (Vector Labs), sealed with nail polish, and visualized using
an epifluorescent microscope (BX61; Olympus). The mean intensity of the
protein signal in a myocyte was measured using Image Pro 6.1 (Media Cyber-
netics). Adobe Photoshop CS and Illustrator CS (Adobe Systems) were used
for processing images.
Mouse ECG Recordings
ECG recordings in mice were carried out as described previously (Tian et al.,
2004b; Zhang et al., 2007). Mice (5–10 months, 30–35 g) were anesthetized
with 0.015 ml/g body weight Avertin (2.5%; Sigma-Aldrich). TA10ETA-F20
transmitters (Data Sciences International) were surgically implanted into the
peritoneal cavity of the NUP155+/ mice. Nontransgenic littermates
(NUP155+/+) were used as controls. After the surgery, the mice were allowed
to recover for 1 week prior to recording of ECG. The Data Sciences telemetry
system was used to continuously monitor and record ECG of conscious, un-
restrainedmice using Data Sciences data acquisition ECG software and saved
on a hard disk for later analysis. Signals below 248 MHz were filtered out.
Nuclear Envelope Permeability Assays
The permeability of the nuclear envelope was measured using a newly devel-
oped assay as described (Grote and Ferrando-May, 2006). In brief, cells on
coverslips (15,000 cells/coverslip) were permeabilized using a low concentra-
tion of digitonin (6 mg/ml). These semipermeabilized cells retained the intact
nuclear membrane. The cells were incubated with cytosolic S-20 extract
and a fluorescent reporter, 70 kDa Texas red-labeled dextran (Molecular
Probes). Cells were then visualized under a microscope. Images were taken
and fluorescence intensity in the nuclei was quantified using Image Pro 6.1
(Media Cybernetics).
Assays for Export of Hsp70 mRNA and Nuclear Import of Hsp70
Protein
Export of Hsp70 mRNA was assayed using RT-PCR analysis of cytoplasmic
and nuclear RNA as described (Kendirgi et al., 2005). The RT-PCR data
were analyzed as described (Pfaffl, 2001). Details are in Supplemental Data.
Nuclear import of Hsp70 protein was measured using immunostaining anal-
yses as previously described (Zeng et al., 2004). A mouse monoclonal anti-
body (Assay Designs, no. SPA-810) was used for a nuclear import assay in
HeLa cells, and a rabbit polyclonal antibody (Assay Designs, no. SPA-812)
was used for the assay in mouse neonatal myocytes.
Statistical Analysis
Data are shown as mean values ± SEM. Statistical analysis was performed us-
ing ANOVA and two-tailed Student’s t tests to compare means, and signifi-
cance was set at the p value of < 0.05.1026 Cell 135, 1017–1027, December 12, 2008 ª2008 Elsevier Inc.SUPPLEMENTAL DATA
Supplemental Data include one table and Supplemental Experimental Proce-
dures and can be found with this article online at http://www.cell.com/
supplemental/S0092-8674(08)01314-7.
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